Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation

Cancer Nanotechnology · Published 2026-07-19 · DOI 10.1186/s12645-026-00404-y

Free full text

Authors (4)

Tahura Fayeghi Arjmand, Ahmad Shojaei, MirAhmad Mazloomi, Effat Alizadeh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Arjmand, T., Shojaei, A., Mazloomi, M., et al. (2026). Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation. Cancer Nanotechnology. https://doi.org/10.1186/s12645-026-00404-y

Related articles

• Harnessing nanotechnology: ellipticine nanoformulations in the fight against cancer · Cancer Nanotechnology · 2026 · Same journal
• Iron–quercetin complex reprograms tumor-associated macrophages toward M1 phenotype and enables MRI tracking in ex vivo tumor-mimicking spheroids · Cancer Nanotechnology · 2026 · Same journal
• Photosensitive gel vaccine with enzyme-like properties for remodeling tumor microenvironment with STING activation for tumor synergistic therapy · Cancer Nanotechnology · 2026 · Same journal
• Potential applications of metal-based nanomaterials in tumor radiotherapy: from x-ray to particle therapies · Cancer Nanotechnology · 2025 · Same journal
• NIR-activated phase-transition thermal-propagation nanosystem for precision photothermal eradication of malignant melanoma · Cancer Nanotechnology · 2026 · Same journal
• Dual-responsive nanohydrogel system for synergistic breast cancer chemotherapy with calcium overload-mediated ion interference therapy · Cancer Nanotechnology · 2026 · Same journal
• Direct-current electric fields tune functionalized gold nanoparticle uptake and mitochondrial remodelling in glioblastoma cells · Cancer Nanotechnology · 2026 · Same journal
• o-carborane encapsulated into polymeric micelles for proton boron capture therapy · Cancer Nanotechnology · 2026 · Same journal
• Synergistic radiosensitization of breast cancer using bismuth oxide nanoparticles coated with chitosan and β-cyclodextrin loaded with curcumin and 5-aminolevulinic acid · Cancer Nanotechnology · 2025 · Same journal
• Recent advances in phytomedicine-based nano-antioxidants for redox-modulated cancer therapy · Cancer Nanotechnology · 2026 · Same journal